Arcus Biosciences, Inc. Announces Underwritten Offering of Common Stock
Portfolio Pulse from
Arcus Biosciences, Inc. announced an underwritten offering of 13,636,364 shares of its common stock at $11.00 per share, aiming to raise approximately $150 million before expenses.
February 18, 2025 | 12:00 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Arcus Biosciences is conducting an underwritten offering of 13,636,364 shares at $11.00 per share, aiming to raise $150 million. This could lead to short-term stock price pressure due to dilution.
The offering increases the total number of shares, potentially diluting existing shareholders' value. This often leads to short-term downward pressure on the stock price as the market adjusts to the increased supply.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100